Background: Accumulating evidence has suggested that nitric oxide (NO) is involved in the regulation of insulin sensitivity in skeletal muscle. Recent studies also suggested NO as an important molecule regulating mitochondrial biogenesis. This study examined the effect of the NO donor, 3-morpholinosydnonimine (SIN-1), on glucose metabolism in skeletal muscle and tested the hypothesis that NO's effect on glucose metabolism is mediated by its effect on mitochondrial function.
Introduction
Nitric oxide (NO) is an important bioactive molecule that plays a variety of role in normal physiological as well as pathological conditions 1, 2) . NO is synthesized by NO synthase (NOS) such as endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) and
NOSs are expressed in skeletal muscle [3] [4] [5] . Accumulating evidence has suggested that exogenous NO stimulates glucose transport in isolated skeletal muscles [6] [7] [8] and
increases glucose transporter isoform 4 (GLUT4) expression in skeletal muscle cells 9) . In addition, it has been reported that eNOS null mice are insulin resistant 10, 11) . These data suggest that NO might be involved in the regulation of insulin sensitivity in skeletal muscle.
Mitochondria are the major site of intracellular respiration and energy metabolism. Mitochondrial function in skeletal muscle is regarded as an important determinant of whole body insulin sensitivity 12) . Recently, it was reported that NO generated by eNOS stimulates mitochondrial biogenesis in skeletal muscle and muscle cells 13) . From these data, we hypothesized that NO improves insulin sensitivity by mediating mitochondrial biogenesis in skeletal muscle.
To examine this hypothesis, we investigated the effect of NO donor, 3-morpholinosydnonimine (SIN-1), on glucose metabolism in skeletal muscle both in vitro and in vivo.
We also investigated the downstream mechanism by which NO mediates glucose metabolism. 
Methods

Glucose Clamp Studies
Glucose clamp experiments were performed as previously described 14) . Briefly, 12-week-old SD rats were fasted for 5 h and subjected to a euglycemic-hyperinsulinemic clamp.
At the end of these euglycemic-hyperinsulinemic clamps, a bolus of 2-deoxy-D-[U-14 C]glucose (2-DG) (20 μCi) was injected to determine the in vivo insulin-stimulated glucose uptake of soleus muscle.
Glucose Uptake in Skeletal Muscle Cells
C2C12 cells were cultured as described above and treated with SIN-1 as indicated in the text. Glucose uptake was performed as previously described 15) . Briefly, the cells were starved in serum-free medium for 2 h and exposed to 100 nM of insulin for 16 h to study basal and insulin-stimulated glucose uptake. Next, we added 2-DG (1 μCi per well) and quantified the incorporation rate.
Triglyceride Content
Triglyceride content in soleus muscle was determined using the Sigma Triglyceride kit (GPO-Trinder) according to the manufacturer's protocol.
Fatty Acid Oxidation
Measurement of fatty acid oxidation of soleus muscle in vitro was performed as described 16) with slight modification.
Fatty acid oxidation was measured using ~50 mg soleus muscle sample excised from rats. These samples were cut into ~5 mg pieces and placed in 5 mL tubes containing 2 . The content of the 5 mL tubes was then placed in a 50 mL tube containing 10 mL 1 N NaOH and a 3 × 5 cm filter paper strip to trap 14 CO2. Incubation was at 37℃ for 1.5 h with oscillation (120 strokes/min), after which 600 μ L of 2 N H2SO4 was injected into the 5 mL tube to release 14 CO2. The 50 mL tube was then held at 55℃ for 3 h to allow transfer of 14 CO2 to the NaOH in the peripheral well.
The filter papers were minced and submerged in the NaOH for 1 h and then the content of peripheral well was transferred to scintillation fluid and counted.
Quantification of Mitochondrial DNA Content
The mitochondrial DNA (mtDNA) content was quantified by an ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA) using the SYBR Green (Qiagen, Valencia, CA) 17) . Total DNA was extracted from muscle tissue of rats using a QIAamp DNA mini kit (Qiagen). The reactions were performed as follows: initial denaturing step at 95℃ for 10 minutes and 40 cycles of Table 1 . 
Western Blot Analysis
Results
SIN-1 Improved Insulin Sensitivity in SD
Rats and C2C12 Cells
Administration of SIN-1 (3 mg/kg/day) for 4 weeks increased glucose infusion rate and 2-DG uptake in soleus muscles from SD rats compared with controls ( Fig 1A &   B ). In accordance with these in vivo data, SIN-1 treatment (0.1 mM) for 18 h of C2C12 cells also increased insulin -stimulated 2-DG uptake, but not basal 2-DG uptake (Fig.   1C ).
SIN-1 Decreased Triglyceride Content and
Increased Fatty Acid Oxidation in Skeletal
Muscle of SD Rats
Triglyceride content in soleus muscle was significantly lower in SIN-1 treated SD rats than in control rats ( Fig.   2A ). Similarly, SIN-1 treatment significantly increased fatty acid oxidation in skeletal muscles (Fig. 2B ). content in soleus muscles of SD rats compared with controls ( Fig. 3A) . In addition, SIN-1 enhanced the expression of PGC-1α, NRF-1, Tfam in soleus muscles of SD rats ( Fig 3B) .
SIN-1 Increased Mitochondrial DNA Content and Biogenesis in Skeletal Muscle of SD Rats
SIN-1 Increased the Phosphorylation of
IRS-1 and Akt in Skeletal Muscle of SD
Rats and C2C12 Cells
To examine whether SIN-1 affects the insulin signaling pathway, we measured phosphorylation of IRS-1 and Akt in skeletal muscle of SD rats and C2C12 cells by but not in basal state (Fig. 4C & 4D ).
Discussion
We demonstrate here that exogenously administered NO donor increases insulin sensitivity by affecting mitochondrial biogenesis and insulin signaling pathway in skeletal muscle.
Mitochondria are the main site of intracellular respiration and energy metabolism. Growing evidence has suggested that NO induces mitochondrial biogenesis and improves mitochondrial function in mammalian cells 13, 18) . In addition, mitochondrial biogenesis was shown to be defective in eNOS null mice 13, 18) . In the present study, Under physiologic conditions, the eNOS is expressed in skeletal muscle 4, 5, 19) and locally produces small amounts of NO. Small amounts of NO produced by eNOS are known to play a key role in the regulation of glucose homeostasis and energy production 19) . Indeed, defective eNOS-driven NO synthesis causes insulin resistance in eNOS null mice 10) and NO donors stimulate glucose transport in isolated rat muscle preparations in vitro 6, 7, 20) . Additionally, the administration of L-NMMA, NOS inhibitor, in vivo resulted in the development of marked insulin resistance [21] [22] [23] and hyperglycemia 23) , suggesting an important role of NO in muscle glucose metabolism. In this study, administration of SIN-1 increased insulin-stimulated glucose uptake in muscle cells. Similarly, administration of SIN-1 increased whole body insulin sensitivity and insulin-stimulated glucose uptake in skeletal muscle of SD rats. Previous reports suggested that the mechanisms of increase in insulin-stimulated glucose transport in vivo involve enhanced blood flow and enhanced glucose delivery to the muscle by NO released from the endothelium 21, 22, 24) . In this study, we observed that NO improved mitochondrial function in skeletal muscle. Taken together with previous studies suggesting mitochondria as an important player in insulin action in peripheral tissues 12) , these data suggest that NO-mediated improvement in mitochondrial function is responsible for improved insulin sensitivity.
NO is known to augment insulin-stimulated glucose uptake by skeletal muscle 21) . Insulin action is mediated through the insulin signaling cascades. Among molecules involved in insulin signaling pathway for glucose uptake, IRS-1 plays a critical role for insulin-stimulated glucose uptake through phosphorylation/activation of its downstream effectors including Akt 25) . In this study, we observed that treatment of SIN-1 increased mtDNA content in skeletal muscle of rats, and also increased phosphorylation of IRS-1 and Akt, both in vitro and in vivo. This is in agreement with previous studies showing that mitochondrial dysfunction in skeletal muscle abolishes insulin activation of IRS-1-PI3-kinase-Akt activity 26) . Additionally, it was reported that in muscle cells depleted of mitochondrial DNA, insulin-stimulated phosphorylation of IRS-1 and Akt2/PKB were drastically reduced 27) . Collectively, it is suggested that cellular mtDNA content modulates insulin signaling pathways, and that NO availability is an important factor that determines mtDNA content.
In summary, we demonstrated that NO increases glucose uptake in skeletal muscle both in vitro and in vivo by improving mitochondrial function and stimulating insulin signaling pathway. However, the precise mechanism that account for relationship between mitochondrial function and insulin signaling pathway has not been documented in this study. Further researches are needed to investigate precise molecular mechanism. 
